Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India.
Genes (Basel). 2020 Sep 21;11(9):1101. doi: 10.3390/genes11091101.
Genome instability is a crucial and early event associated with an increased predisposition to tumor formation. In the absence of any exogenous agent, a single human cell is subjected to about 70,000 DNA lesions each day. It has now been shown that physiological cellular processes including DNA transactions during DNA replication and transcription contribute to DNA damage and induce DNA damage responses in the cell. These processes are also influenced by the three dimensional-chromatin architecture and epigenetic regulation which are altered during the malignant transformation of cells. In this review, we have discussed recent insights about how replication stress, oncogene activation, chromatin dynamics, and the illegitimate recombination of cell-free chromatin particles deregulate cellular processes in cancer cells and contribute to their evolution. The characterization of such endogenous sources of genome instability in cancer cells can be exploited for the development of new biomarkers and more effective therapies for cancer treatment.
基因组不稳定性是与肿瘤形成易感性增加相关的关键早期事件。在没有任何外源因子的情况下,单个人类细胞每天会遭受约 70000 次 DNA 损伤。现在已经表明,包括 DNA 复制和转录过程中的 DNA 交易在内的生理细胞过程会导致 DNA 损伤,并在细胞中诱导 DNA 损伤反应。这些过程还受到三维染色质结构和表观遗传调控的影响,而这些在细胞恶性转化过程中会发生改变。在这篇综述中,我们讨论了最近的一些见解,即复制应激、癌基因激活、染色质动力学以及游离染色质颗粒的非同源重组如何使癌细胞中的细胞过程失控,并促进其进化。对癌细胞中这种内源性基因组不稳定性来源的特征可以用于开发新的生物标志物和更有效的癌症治疗方法。